$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Inhalation device 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61M-015/00
출원번호 US-0939615 (1978-09-05)
발명자 / 주소
  • Carris Milton C. (Cupertino CA)
출원인 / 주소
  • Syntex Puerto Rico, Inc. (Humacao PR 02)
인용정보 피인용 횟수 : 54  인용 특허 : 2

초록

An inhalation device for dispensing a powdered medicament from a medicament-holding container having a first part which is an elongate housing having a passageway for the movement of air therethrough, one end of the housing being an output end adapted for insertion into the mouth or nasal passage of

대표청구항

A two-part breath-actuated inhalation device for dispensing a powdered medicament from a powdered medicament-holding container, the first part of said device comprising an elongate housing having a passageway for the movement of air therethrough, one end of said housing being an output end adapted f

이 특허에 인용된 특허 (2)

  1. Lundquist Ingemar H. (Oakland CA), Inhalation device.
  2. Cocozza Salvatore (Milan IT), Inhalers and insufflators having a cutting means.

이 특허를 인용한 특허 (54)

  1. Harrison,Ian, Apparatus for the nasal or oral delivery of a medicament.
  2. DeBrabander, Jef; Parada, Luis, Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers.
  3. Panitch, Alyssa; Seal, Brandon, Cell-permeant peptide-based inhibitor of kinases.
  4. Hoekman, John D.; Ho, Rodney J. Y., Circumferential aerosol device.
  5. Platz, Robert M.; Patton, John S.; Foster, Linda; Eljamal, Mohammed, Composition for pulmonary administration comprising a drug and a hydrophobic amino acid.
  6. Panitch, Alyssa; Seal, Brandon; Brugnano, Jamie L.; Bartlett, Rush L.; Sharma, Shaili; McMasters, James, Compositions and methods for delivery of kinase inhibiting peptides.
  7. Panitch, Alyssa; Seal, Brandon; Brugnano, Jamie L.; Bartlett, Rush L.; Sharma, Shaili; McMasters, James, Compositions and methods for delivery of kinase inhibiting peptides.
  8. Stock, Jeffry B.; Stock, Maxwell; Gu, Haoming; Stock, Gregory B; Li, Zhu; Wolanin, Peter Michael, Compositions and methods for enhancing cognitive function.
  9. Lander, Cynthia; Brophy, Colleen, Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition.
  10. Lander, Cynthia; Brophy, Colleen, Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition.
  11. Platz, Robert M.; Patton, John S.; Foster, Linda; Eljamal, Mohammed, Compositions and methods for the pulmonary delivery of aerosolized macromolecules.
  12. Platz,Robert M.; Patton,John S.; Foster,Linda; Eljamal,Mohammed, Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments.
  13. Yuan, Rui Rong; Li, Wei Ping; Maeda, Yasuhiro; Dowling, Peter, Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators.
  14. Yuan, Rui Rong; Li, Wei Ping; Maeda, Yasuhiro; Dowling, Peter C., Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators.
  15. Yuan, Rui Rong; Li, Wei Ping; Maeda, Yasuhiro; Dowling, Peter C., Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators.
  16. Clark, Andrew; Schuler, Carlos; Paboojian, Steve, Flow resistance modulated aerosolized active agent delivery.
  17. Lander, Cynthia; Brophy, Colleen; Peterson, Caryn, Formulation of MK2 inhibitor peptides.
  18. Farr, Philip William, Inhalation device.
  19. Volgyesi George,CAX, Inhalation device.
  20. Volgyesi, George, Inhalation device.
  21. Ohki, Hisatomo; Yazawa, Yoshiyuki; Nakamura, Shigemi; Yokobori, Mitsuru; Ishizeki, Kazunori, Inhalator for administering powder composition.
  22. Keller Manfred,DEX ; Eggimann Thomas,CHX, Inhaler for multiple dosed administration of a pharmacological dry powder.
  23. Keller,Manfred; Eggimann,Thomas, Inhaler for multiple dosed administration of a pharmacological dry powder.
  24. Campbell, H. Stuart; Shanks, Thomas, Inhaler mouthpiece.
  25. Panitch, Alyssa; Seal, Brandon; Ward, Brian, Kinase inhibitors and uses thereof.
  26. Panitch, Alyssa; Seal, Brandon; Ward, Brian, Kinase inhibitors and uses thereof.
  27. Tezapsidis, Nikolaos, Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology.
  28. Tezapsidis, Nikolaos; Greco, Steven J.; Smith, Mark, Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta.
  29. Panitch, Alyssa; Otto, Kevin; Onunkwo, Nnadozie; Woolley, Andrew, MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration.
  30. Stock, Gregory; Stock, Jeffry B.; Stock, Maxwell; Vafai, Scott, Method of identifying modulators of PP2A methylase.
  31. Wang, Bo; Yuan, Rui R.; Lu, Wei; Dowling, Peter, Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides.
  32. Wang, Bo; Yuan, Rui Rong; Lu, Wei; Dowling, Peter C., Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides.
  33. Tezapsidis, Nikolaos; Greco, Steven; Smith, Mark, Methods for treating progressive cognitive disorders related to neurofibrillary tangles.
  34. Pilkiewicz, Frank G.; Perez-Soler, Roman; Zou, Yiyu; Perkins, Walter R.; Lee, Jin K.; Malinin, Vladimir, Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally.
  35. Campbell, H. Stuart; Shanks, Thomas, Mouthpiece for inhalers.
  36. Djupesland, Per Gisle, Nasal delivery.
  37. Djupesland, Per Gisle, Nasal delivery.
  38. Hoekman, John D.; Hite, Michael; Brunelle, Alan; Relethford, Joel; Ho, Rodney J. Y., Nasal drug delivery device.
  39. Hoekman, John D.; Hite, Michael; Brunelle, Alan; Relethford, Joel, Nozzles for nasal drug delivery.
  40. Keller, Manfred; Eggimann, Thomas, Pharmacological inhaler.
  41. Panitch, Alyssa, Polypeptide for treating or preventing adhesions.
  42. Panitch, Alyssa; Seal, Brandon; Ward, Brian, Polypeptide inhibitors of HSP27 kinase and uses therefor.
  43. Panitch, Alyssa; Seal, Brandon; Ward, Brian C., Polypeptide inhibitors of HSP27 kinase and uses therefor.
  44. Panitch, Alyssa; Seal, Brandon; Ward, Brian P., Polypeptide inhibitors of HSP27 kinase and uses therfor.
  45. Oliva,Roberto, Single dose inhaler.
  46. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  47. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  48. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  49. Gordon, Marc S.; Clark, Andrew; Brewer, Thomas K., Systems and processes for spray drying hydrophobic and hydrophilic components.
  50. De Brabander, Jef; Shay, Jerry W.; Wang, Wentian; Nijhawan, Deepak; Theodoropoulos, Pano, Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis.
  51. De Brabander, Jef; Shay, Jerry W.; Wang, Wentian, Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins.
  52. Lu, Wei; Dowling, Peter C.; Yuan, Rui Rong, Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders.
  53. Lander, Cynthia; Brophy, Colleen; Peterson, Caryn; Luber, Andrew, Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same.
  54. Schwartz, David; Iyengar, Sujatha, Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로